COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION

Aim. To study efficiency and safety of new drug of long acting metoprolol tartrate, “Egilok retard” (ER) in patients with mild to moderate arterial hypertension (AH) in comparison with the original drug of metoprolol succinat, “Betaloc ZOK” (BZ), possibility of reaching target blood pressure (BP) le...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	J. V. Lukina, A. D. Deev, N. A. Dmitrieva, N. Y. Ivanenkova, A. A. Serazhim, G. F. Andreeva, S. Y. Martsevich
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Столичная издательская компания 2015-12-01
Seri Bilgileri:	Рациональная фармакотерапия в кардиологии
Konular:	metoprolol tartrate metoprolol succinate arterial hypertension antihypertensive therapy
Online Erişim:	https://www.rpcardio.online/jour/article/view/367
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!